| 1 | Receive Directors' Reports (Non-Voting)
| Non-Voting |
| 2 | Receive Auditors' Reports (Non-Voting)
| Non-Voting |
| 3 | Receive Consolidated Financial Statements and Statutory Reports (Non-Voting)
| Non-Voting |
| 4 | Approve Financial Statements, Allocation of Income, and Dividends of EUR 1.27 per Share
| For |
| 5 | Approve the Remuneration Report | Oppose |
| 6 | Approve Remuneration Policy | Oppose |
| 7 | Discharge the Board | For |
| 8 | Discharge the Auditors | Oppose |
| 9.1.A | Elect Stefan Oschmann - Chair (Non Executive) | For |
| 9.1.B | Classify Director as Independent: Stefan Oschman | For |
| 9.2 | Elect Fiona du Monceau - Vice Chair (Non Executive) | For |
| 9.3.A | Ratify the Co-optation of Susan Gasser as Independent Director
| For |
| 9.3.B | Elect Susan Gasser - Non-Executive Director | For |
| 9.3.C | Classify Director as Independent: Susan Gasser | For |
| 9.4.A | Elect Jonathan Peacock - Non-Executive Director | For |
| 9.4.B | Classify Director as Independent: Jonathan Peacock | For |
| 9.5.A | Elect Albrecht De Graeve - Non-Executive Director | For |
| 9.5.B | Classify Director as Independent: Albrecht De Graeve | Oppose |
| 9.6.A | Elect Viviane Monges - Non-Executive Director | For |
| 9.6.B | Classify Director as Independent: Viviane Monges | For |
| 10 | Appoint the Auditors | For |
| 11 | Approve New Long Term Incentive Plan | Oppose |
| 12.1 | Approve Adoption of Anti-takeover Measure (poison pill) | Oppose |
